Related Experiment Video

Updated: May 30, 2026

A Novel Method: Super-selective Adrenal Venous Sampling
06:08

A Novel Method: Super-selective Adrenal Venous Sampling

Published on: September 15, 2017

Clinical characteristics of primary hyperaldosteronism due to adrenal microadenoma

Shigehiro Karashima1, Yoshiyu Takeda, Yuan Cheng

  • 1Department of Internal Medicine, Graduate School of Medical Science, Kanazawa University, Kanazawa 920-8641, Japan.

Steroids
|August 2, 2011
PubMed

Insights

Primary aldosteronism patients with adrenal microadenomas exhibit higher diastolic blood pressure. Gene expression analysis reveals increased CYP11B2 and CYP17 mRNA in microadenoma-adjacent tissues, suggesting a distinct pathophysiology for microadenomas.

Area of Science:

  • Endocrinology
  • Molecular Biology
  • Pathology

Background:

  • Primary aldosteronism (PA) is increasingly diagnosed, often due to aldosterone-producing macroadenomas (APA).
  • Limited data exists on the clinical characteristics of PA associated with adrenal microadenomas.
  • Understanding PA subtypes is crucial for effective patient management.

Purpose of the Study:

  • To compare the clinical features of PA patients with microadenoma, macroadenoma, and idiopathic hyperaldosteronism (IHA).
  • To investigate the gene expression of steroidogenic enzymes in adrenal tissues adjacent to microadenomas and macroadenomas.
  • To elucidate the underlying mechanisms of aldosterone overproduction in different PA subtypes.

Main Methods:

  • Retrospective analysis of 55 PA patients diagnosed with unilateral aldosterone overproduction.
  • Histopathological examination of surgically removed adrenal tissues to classify microadenoma and macroadenoma.
  • Real-time PCR to quantify mRNA expression of CYP11B2, CYP17, CYP21, and HSD3B2 in adjacent adrenal cortices.
  • Comparison of clinical parameters including blood pressure, plasma aldosterone, serum potassium, and renal function.

Main Results:

  • Patients with microadenoma (n=6) showed significantly higher diastolic blood pressure compared to macroadenoma (n=16) and IHA (n=33) groups (p<0.05).
  • Increased CYP11B2 and CYP17 mRNA levels were observed in adrenal tissues adjacent to microadenomas compared to macroadenomas and non-functioning adenomas (NF) (p<0.05).
  • Tumor size did not influence clinical characteristics; microadenomas demonstrated sustained CYP11B2 expression under suppressed renin-angiotensin system.

Conclusions:

  • Adrenal microadenomas in PA are associated with distinct clinical features, notably higher diastolic blood pressure.
  • Elevated CYP11B2 and CYP17 mRNA expression in tissues surrounding microadenomas suggests a localized molecular basis for hyperaldosteronism.
  • Further investigation, including increased microadenoma sampling and immunohistochemistry, is warranted to clarify the etiology of microadenoma-related PA.

More Related Videos

Endoscopic Endonasal Trans-sphenoidal Approach: Minimally Invasive Surgery for Pituitary Adenomas07:43

Endoscopic Endonasal Trans-sphenoidal Approach: Minimally Invasive Surgery for Pituitary Adenomas

Published on: January 17, 2018

Primary Culture of Rat Adrenocortical Cells and Assays of Steroidogenic Functions04:33

Primary Culture of Rat Adrenocortical Cells and Assays of Steroidogenic Functions

Published on: March 12, 2019

Related Concept Videos

Adrenal Gland Disorders01:27

Adrenal Gland Disorders

Adrenal gland disorders manifest when the production of adrenal hormones deviates from the norm, resulting in either excessive or insufficient concentrations.
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
Cushing Syndrome I: Introduction01:26

Cushing Syndrome I: Introduction

Cushing syndrome refers to the collection of clinical manifestations that arise when tissues are exposed to excessive amounts of cortisol or cortisol-like medications over an extended period. Cortisol, a glucocorticoid produced by the adrenal cortex, regulates metabolism, immune responses, and the body’s adaptation to stress. When its concentration remains chronically elevated, these physiological pathways become dysregulated, resulting in the characteristic features of the syndrome.Exogenous...
Cushing Syndrome II: Pathophysiology01:19

Cushing Syndrome II: Pathophysiology

Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features of the...
Hyperthyroidism I: Introduction01:25

Hyperthyroidism I: Introduction

Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
Antihypertensive Drugs: Potassium-Sparing Diuretics01:28

Antihypertensive Drugs: Potassium-Sparing Diuretics

Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
Graves Disease II: Pathophysiology01:24

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...